SOAT1 and acute myeloid leukemia: While previous studies have revealed various mechanisms behind the anti-leukemia effects of TQ [30,31], in this study, we identify hypomethylation of JAK/STAT-negative regulator genes as previously unstudied epigenetic alterations that mediate TQ’s anti-leukemic activities in AML.